https://clinicaltrials.gov/study/NCT05746572?term=mdma%20ptsd%20and%20emory&rank=1&a=8 Emory University plans #fda Phase 2 study of #mdma plus a type of behavioral #psychotherapy called Exposure Therapy for the treatment of #ptsd — This study is unrelated to the MAPS/Lykos new drug application for #mdmaassistedtherapy and a reminder #psychedelic #research is robust and ongoing. #studydesign should include blinding with #ketamine and comparison to #cognitivebehavioraltherapy #psychedelics